08Jan 2019

LE SYNDROME DE PRADER WILLI A L AGE DE L ADOLESCENCE : DIFFICULTES DE PRISE EN CHARGE : A PROPOS DE DEUX CAS.

  • Service D?endocrinologie, Diabetologie Et Maladies Metaboliques, Chu Mohammed Vi, Hopital Errazi, Marrakech.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Prader-Willi syndrome (PWS) is a rare disease first described in 1956. It is an important part of mental retardation related to a genetic cause and is one of the leading causes of syndromic obesity in children. It is responsible for physical, psychological and social disabilities of a particular gravity. The diagnosis is evoked on clinical elements and confirmed only by genetic analysis. The management of this disease is multidisciplinary and can be extremely difficult in the teenage age due to behavioral disorders and the total lack of autonomy of patients. We report the case of two patients followed in our training for the treatment of PraderWilli syndrome in adolescence with severe behavioral disorders.


  1. Ma?th?Tauber, Gwena?lleDi?nea, M?lanieGlattard, EricBieth (2006)?: Le syndrome de PraderWilli?: mtp?diatrie, vol. 9, n? 4, juillet-ao?t .
  2. Bach?re N, Diene G, Moulin P, Tauber M (2004): Evolution of young children with PraderWilli syndrome diagnosed during the first twomonths of life and managed by a multidisciplinary team. 43th annualmeeting for the European Society for Pediatric Endocrinology. Basel.
  3. Prader A, Labhart A, Willi H (1956) EinSyndrom von Adipositas, Kleinwuchs, Kryptoorchismus und OligophrenienachMyatonieartigemZustandimNeugeborenenalter. Schweiz Med Wschr 86:1260?1261
  4. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M (2004). Genetic imprinting suggested by maternal heterodisomy in nondeletionPrader-Willi syndrome. Nature 1989;342:281-285.
  5. Goldstone AP (2004) .Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab;15:12-20.
  6. Diene , A. Postel-Vinay , G. Pinto , M. Polak , M. Tauber (2007). Le syndrome de PraderWilli. Annalesd\'EndocrinologieVol 68, N? 2-3 - pp. 129 137Doi10.1016/j.ando.2007.03.002
  7. Crino A, Schiaffini R, Ciampalini P, et al (2003). Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr;162:327-333.
  8. Eiholzer U, l?Allemand D, Rousson V, et al (2006). Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J ClinEndocrinol Metab;91:892-898.
  9. Craig ME, Cowell CT, Larsson P, et al (2006). Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). ClinEndocrinol (Oxf) ;65:178-185.
  10. Whittington J, Holland A, Webb T, Butler J, Clarke D, Boer H (2004). Cognitive abilities and genotype in a population-based sample people with Prader-Willi syndrome. J Intellect DisabilRes ;48:172-187.
  11. Whittington J, Holland A, Webb T, Butler J, Clarke D, Boer H (2004). Academic underachievement by people with Prader-Willi syndrome. J Intellect DisabilRes ;48:188-200.
  12. Whittington J, Holland T (2004). Prader-Willi syndrome: development and manifestations. Cambridge: University Press.
  13. Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D (2002). Psychotic illness in people with PraderWilli syndrome due to chromosome 15 maternal uniparentaldisomy. Lancet ;359:135-136.
  14. Miller J, Kranzler J, Liu Y, et al (2006). Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J Pediatr ;149:192-198.
  15. Tauber M, Barbeau C, Jouret B, et al (2000). Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. HormRes ;53:279-287.
  16. Hoybye C, Hilding A, Jacobson H, Thoren M (2002). Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J ClinEndocrinolMetab ;87:3590-3597.
  17. Eiholzer U, l?Allemand D, Rousson V, et al (2006). Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J ClinEndocrinol Metab;91:892-898.

[Nassiba Elouarradi , Ghizlane Elmghari and Nawal Elansari. (2019); LE SYNDROME DE PRADER WILLI A L AGE DE L ADOLESCENCE : DIFFICULTES DE PRISE EN CHARGE : A PROPOS DE DEUX CAS. Int. J. of Adv. Res. 7 (Jan). 417-420] (ISSN 2320-5407). www.journalijar.com


Nassiba Elouarradi
Department of Endocrinology, Diabetology and Metabolic Diseases, Mohammed VI Hospital, Errazi Hospital, Marrakech, Morocco.

DOI:


Article DOI: 10.21474/IJAR01/8345      
DOI URL: https://dx.doi.org/10.21474/IJAR01/8345